Pesquisar
Precigen Inc
PGENAdicionar à lista de desejos
7.700USD
-0.080-1.03%
Fechamento 09-21 16:00（ET）
2.76BValor de mercado
PerdaP/L TTM
Sobre o {index_name} Precigen Inc Empresa
Precigen, Inc. is a discovery and clinical-stage biopharmaceutical company developing gene and cell therapies for improving outcomes for patients with unmet medical needs. The Company’s proprietary technology platforms develop product candidates designed to target urgent and intractable diseases in its core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. It has developed a pipeline of therapies across multiple indications. The Company’s segments include Biopharmaceuticals and Exemplar. The Biopharmaceuticals segment is primarily comprised of the Company's legal entities as well as royalty interests in therapeutics and therapeutic platforms from companies not controlled by the Company. The Exemplar is composed of Exemplar Genetics LLC, doing business as Precigen Exemplar, its wholly owned subsidiary focused on developing research models and services for healthcare research applications.
Precigen Inc Perfil
Código da empresaPGEN
Nome da EmpresaPrecigen Inc
Data de listagemAug 08, 2013
CEOSabzevari (Helen)
Número de funcionários143
Tipo de títulosOrdinary Share
Fim do ano fiscalAug 08
Endereço20374 Seneca Meadows Parkway
CidadeGERMANTOWN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal20876
Telefone13015569900
Sitehttps://precigen.com/
Código da empresaPGEN
Data de listagemAug 08, 2013
CEOSabzevari (Helen)
Executivos da empresa Precigen Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Helen Sabzevari, Ph.D.
Dr. Helen Sabzevari, Ph.D.
President, Chief Executive Officer, Director, President of PGEN Therapeutics, Inc.
President, Chief Executive Officer, Director, President of PGEN Therapeutics, Inc.
3.78M
+0.28%
Dr. Helen Sabzevari, Ph.D.
Dr. Helen Sabzevari, Ph.D.
President, Chief Executive Officer, Director, President of PGEN Therapeutics, Inc.
President, Chief Executive Officer, Director, President of PGEN Therapeutics, Inc.
3.78M
+0.28%
Dr. Helen Sabzevari, Ph.D.
Dr. Helen Sabzevari, Ph.D.
President, Chief Executive Officer, Director, President of PGEN Therapeutics, Inc.
President, Chief Executive Officer, Director, President of PGEN Therapeutics, Inc.
3.78M
+0.28%
Mr. Fred Hassan
Mr. Fred Hassan
Independent Director
Independent Director
1.24M
+7.22%
Mr. Fred Hassan
Mr. Fred Hassan
Independent Director
Independent Director
1.24M
+7.22%
Mr. Fred Hassan
Mr. Fred Hassan
Independent Director
Independent Director
1.24M
+7.22%
Mr. Steven R. Frank
Mr. Steven R. Frank
Independent Director
Independent Director
1.23M
+7.02%
Mr. Steven R. Frank
Mr. Steven R. Frank
Independent Director
Independent Director
1.23M
+7.02%
Mr. Steven R. Frank
Mr. Steven R. Frank
Independent Director
Independent Director
1.23M
+7.02%
Mr. James S. (Jim) Turley
Mr. James S. (Jim) Turley
Lead Independent Director
Lead Independent Director
685.42K
+13.08%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Helen Sabzevari, Ph.D.
Dr. Helen Sabzevari, Ph.D.
President, Chief Executive Officer, Director, President of PGEN Therapeutics, Inc.
President, Chief Executive Officer, Director, President of PGEN Therapeutics, Inc.
3.78M
+0.28%
Dr. Helen Sabzevari, Ph.D.
Dr. Helen Sabzevari, Ph.D.
President, Chief Executive Officer, Director, President of PGEN Therapeutics, Inc.
President, Chief Executive Officer, Director, President of PGEN Therapeutics, Inc.
3.78M
+0.28%
Dr. Helen Sabzevari, Ph.D.
Dr. Helen Sabzevari, Ph.D.
President, Chief Executive Officer, Director, President of PGEN Therapeutics, Inc.
President, Chief Executive Officer, Director, President of PGEN Therapeutics, Inc.
3.78M
+0.28%
Mr. Fred Hassan
Mr. Fred Hassan
Independent Director
Independent Director
1.24M
+7.22%
Mr. Fred Hassan
Mr. Fred Hassan
Independent Director
Independent Director
1.24M
+7.22%
Mr. Fred Hassan
Mr. Fred Hassan
Independent Director
Independent Director
1.24M
+7.22%
Perguntas frequentes
Quem são os cinco principais acionistas de Precigen Inc?
Os cinco principais acionistas de Precigen Inc são: Dr. Helen Sabzevari, Ph.D.
Quantas instituições possuem ações da Precigen Inc (PGEN)?
Em 2026Q1, 355 instituições possuíam ações da Precigen Inc, com valor de mercado aproximado de 270.08M, representando 75.82% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 16216262.00.
Qual é a maior fonte de receita da Precigen Inc?
Em 2026Q1, o segmento de negócios Product gerou a maior receita para Precigen Inc, totalizando 53.26M e representando 96.88% da receita total.